New Swine Claim for Lincomix® Provides Flexible Dosing for M. hyo

January 16, 2018 — 

Pork producers battling swine respiratory disease associated with Mycoplasma hyopneumoniae (M. hyo) now have more flexibility when using Lincomix® (lincomycin hydrochloride) Type A medicated article, thanks to a new dosing level approved by the U.S. Food and Drug Administration. [Source: Zoetis Press Release, January 12, 2018]

Lincomix® may now be administered at 100 to 200 grams per ton of feed for 21 days to reduce the severity of respiratory disease associated with M. hyo. Previously, Lincomix® had to be used at the rate of 200 grams per ton of feed to reduce the severity of swine respiratory disease caused by M. hyo.

The 100-gram dose rate is also approved for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis and the treatment of swine dysentery.